You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Infigratinib Phosphate

Showing 1 - 25 of 896
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Resectable Intrahepatic Cholangiocarcinoma, Stage 0 Intrahepatic Cholangiocarcinoma AJCC v8, Stage I Intrahepatic

Not yet recruiting
  • Resectable Intrahepatic Cholangiocarcinoma
  • +4 more
  • Atlanta, Georgia
  • +2 more
Aug 19, 2022

Upper Tract Urothelial Carcinomas, Urothelial Bladder Cancer Trial in Worldwide (Infigratinib, Placebo)

Recruiting
  • Upper Tract Urothelial Carcinomas
  • Urothelial Bladder Cancer
  • Tucson, Arizona
  • +133 more
Apr 25, 2022

Advanced Solid Tumor, CNS Tumor, Recurrent WHO Grade II Glioma Trial in Canada, Germany, United States (Infigratinib)

Not yet recruiting
  • Advanced Solid Tumor
  • +2 more
  • Palo Alto, California
  • +9 more
Aug 2, 2022

Advanced Cholangiocarcinoma, FGFR2 Gene Mutation Trial in Worldwide (BGJ398, Gemcitabine, Cisplatin)

Active, not recruiting
  • Advanced Cholangiocarcinoma
  • FGFR2 Gene Mutation
  • Gilbert, Arizona
  • +115 more
Oct 17, 2022

Renal Pelvis and Ureter Urothelial Carcinoma Trial in Houston (drug, other, procedure)

Active, not recruiting
  • Renal Pelvis and Ureter Urothelial Carcinoma
  • Houston, Texas
    M D Anderson Cancer Center
Jul 21, 2022

Cholangiocarcinoma, Liver Cancer Trial in Houston (Infigratinib, Atezolizumab, Bevacizumab)

Not yet recruiting
  • Cholangiocarcinoma
  • Liver Cancer
  • Houston, Texas
    M D Anderson Cancer Center
Aug 18, 2022

Achondroplasia Trial in Worldwide (Infigratinib 0.016 mg/kg, Infigratinib 0.032 mg/kg, Infigratinib 0.064 mg/kg)

Recruiting
  • Achondroplasia
  • Infigratinib 0.016 mg/kg
  • +3 more
  • Oakland, California
  • +17 more
Apr 5, 2022

Achondroplasia Trial in Australia, Spain, United Kingdom (Infigratinib)

Recruiting
  • Achondroplasia
  • Parkville, Victoria, Australia
  • +3 more
Apr 5, 2022

Bladder Transitional Cell Carcinoma, Bladder Cancer, Fibroblast Growth Factor Receptor Trial (Infigratinib)

Withdrawn
  • Bladder Transitional Cell Carcinoma
  • +2 more
  • (no location specified)
Aug 8, 2022

Advanced Malignant Solid Tumor, Cholangiocarcinoma, Metastatic Malignant Solid Tumor Trial in Columbus (Infigratinib)

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +3 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Feb 15, 2022

Breast Cancer, HER2-negative Breast Cancer, ER Positive Breast Cancer Trial in Stanford (Infigratinib, Tamoxifen, Omnipaque 350)

Recruiting
  • Breast Cancer
  • +3 more
  • Stanford, California
    Stanford University
Feb 16, 2022

Drug Interaction Trial in Beijing (ZX-7101A, Oseltamivir, ZX-7101A and Oseltamivir)

Recruiting
  • Drug Interaction
  • Beijing, Beijing, China
    Peking University Third Hospital
Sep 21, 2023

Kidney Failure, Chronic, Hyperphosphatemia Trial in Worldwide (Liberal phosphate target, Intensive phosphate target)

Recruiting
  • Kidney Failure, Chronic
  • Hyperphosphatemia
  • Liberal phosphate target
  • Intensive phosphate target
  • Camperdown, New South Wales, Australia
  • +70 more
Dec 5, 2022

Calcium Phosphate Kidney Stones Trial (OHCit- standard dose, Potassium Citrate, Placebo)

Not yet recruiting
  • Calcium Phosphate Kidney Stones
  • OHCit- standard dose
  • +3 more
  • (no location specified)
Aug 14, 2023

Chronic Kidney Disease Requiring Chronic Dialysis, Hyperphosphatemia Trial in Lauderdale Lakes (Tenapanor)

Completed
  • Chronic Kidney Disease Requiring Chronic Dialysis
  • Hyperphosphatemia
  • Lauderdale Lakes, Florida
    South Florida Research Institute
Sep 28, 2022

Glioma, Glioblastoma, GBM Trial in Chandler, Phoenix, Scottsdale (Infigratinib)

Recruiting
  • Glioma
  • +2 more
  • Chandler, Arizona
  • +2 more
Mar 10, 2022

Hyperphosphatemia, Anemia, Iron Deficiency, Renal Insufficiency Trial in United States (Ferric Citrate 1 gram Oral Tablet,

Completed
  • Hyperphosphatemia
  • +2 more
  • Ferric Citrate 1 gram Oral Tablet
  • Standard of care phosphate-lowering therapy
  • Anchorage, Alaska
  • +12 more
Nov 3, 2022

Healthy Trial (Iron fortified milk with iron salt labelled with 58Fe and 57Fe)

Completed
  • Healthy
  • Iron fortified milk with iron salt labelled with 58Fe and 57Fe
  • (no location specified)
Nov 30, 2022

Metastatic Malignant Tumor in the Bone, Stage IV Breast Cancer AJCC v6 and v7, Triple-Negative Breast Carcinoma Trial in

Active, not recruiting
  • Metastatic Malignant Neoplasm in the Bone
  • +2 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Scottsdale, Arizona
    Mayo Clinic in Arizona
Jan 4, 2023

Heart Failure Trial in Osaka (Samtasu for I.V. infusion)

Not yet recruiting
  • Heart Failure
  • Samtasu for I.V. infusion
  • Osaka, Japan
    Pharmacovigilance Department
Jan 25, 2023

Periodontitis Trial (coronally advanced flap, Nanocrystalline hydroxyapatite loaded in PRF, Nanocrystalline tricalcium phosphate

Completed
  • Periodontitis
  • coronally advanced flap
  • +2 more
  • (no location specified)
Aug 24, 2023

Caries Trial (MI varnish)

Not yet recruiting
  • Caries
  • MI varnish
  • (no location specified)
Oct 22, 2023

Stage I Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia, Stage III Chronic Lymphocytic Leukemia Trial in

Active, not recruiting
Has Results
  • Stage I Chronic Lymphocytic Leukemia
  • +3 more
  • Scottsdale, Arizona
  • +363 more
Dec 30, 2022

Cholera Vaccination Reaction Trial in Seoul (OSP:rTTHc Cholera Conjugate Vaccine Cohort A, OSP:rTTHc Cholera Conjugate Vaccine

Recruiting
  • Cholera Vaccination Reaction
  • OSP:rTTHc Cholera Conjugate Vaccine Cohort A
  • +8 more
  • Seoul, Korea, Republic of
  • +2 more
Nov 30, 2022

Newborn Phosphocalcic Metabolism After Intravenous Iron

Completed
  • Iron Induced Hypophosphatemia
  • IV iron administration
  • Geneva, Switzerland
    Geneva University Hospitals
Oct 27, 2023